通过抑制HDAC4,LMK-235可以抑制骨质细胞形成,并通过抑制HDAC4促进骨质细胞形成

Chongwei Chen1, Yue Li2, Teng Feng1

  • 1Shanxi Key Lab of Bone and Soft Tissue Injury Repair, Department of Orthopedics, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.

Scientific reports
|August 28, 2024
PubMed
概括

LMK-235是一种选择性的HDAC4/5抑制剂,抑制骨质细胞活性,增强骨质细胞功能. 这种双重作用显示了治疗骨质疏松症和骨质溶解等骨疾病的潜力.